Cannulation of the Suprachoroidal Space: A Novel Drug Delivery Methodology to the Posterior Segment

American Journal of Ophthalmology

Volumn 142, Issue 5, 2006, Pages

  Olsen, Timothy W ^a   Feng, Xiao ^a   Wabner, Kathy ^a   Conston, Stanley R ^b   Sierra, David H ^b   Folden, David V ^a   Smith, Morton E ^c   Cameron, J Douglas ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b iScience Surgical Corp   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; FLUORESCEIN; INDOCYANINE GREEN; TRACER; TRIAMCINOLONE;

ABSCESS; ANIMAL TISSUE; ARTICLE; CANNULA; CANNULATION; CHOROID; CONNECTIVE TISSUE; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; ENDOPHTHALMITIS; ENUCLEATION; FIBER OPTICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILLUMINATION; MACACA; METHODOLOGY; NONHUMAN; OPTIC NERVE; POSTERIOR EYE CHAMBER; POSTOPERATIVE INFLAMMATION; PRIMATE; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA MACULA LUTEA; SCANNING LASER OPHTHALMOSCOPY; SCLERA DISEASE; SURGICAL TECHNIQUE; SWINE;

EID: 33750086968     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.05.045     Document Type: Article

References (25)

1. Geroski D.H., and Edelhauser H.F. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci 41 (2000) 961-964
2. Olsen T.W., Edelhauser H.F., Lim J.I., and Geroski D.H. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci 36 (1995) 1893-1903
3. Olsen T.W., Aaberg S.Y., Geroski D.H., and Edelhauser H.F. Human sclera: thickness and surface area. Am J Ophthalmol 125 (1998) 237-241
4. Aiello L.P., Brucker A.J., Chang S., et al. Evolving guidelines for intravitreous injections. Retina 24 (2004) S3-S19
5. Martin D.F., Parks D.J., Mellow S.D., et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial. Arch Ophthalmol 112 (1994) 1531-1539
6. Jaffe G.J., McCallum R.M., Branchaud B., et al. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology 112 (2005) 1192-1198
7. Jaffe G.J., Yang C.H., Guo H., et al. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci 41 (2000) 3569-3575
8. Martin D.F., Ferris F.L., Parks D.J., et al. Ganciclovir implant exchange: timing, surgical procedure, and complications. Arch Ophthalmol 115 (1997) 1389-1394
9. Guyer D., Schachat A., and Green R. The choroid: structural considerations. In: Ryan S. (Ed). Retina. 4th ed (2006), CV Mosby, St Louis, Missouri 33-42
10. Krohn J., and Bertelsen T. Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the human eye. Acta Ophthalmol Scand 75 (1997) 32-35
11. Krohn J., and Bertelsen T. Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the pig eye. Acta Ophthalmol Scand 75 (1997) 28-31
12. Krohn J., and Bertelsen T. Light microscopy of uveoscleral drainage routes after gelatine injections into the suprachoroidal space. Acta Ophthalmol Scand 76 (1998) 521-527
13. Einmahl S., Savoldelli M., D'Hermies F., et al. Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci 43 (2002) 1533-1539
14. Poole T.A., and Sudarsky R.D. Suprachoroidal implantation for the treatment of retinal detachment. Ophthalmology 93 (1986) 1408-1412
15. Schindler R.H., Chandler D., Thresher R., and Machemer R. The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 93 (1982) 415-417
16. Gragoudas E.S., Adamis A.P., Cunningham E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
17. Smithen L.M., and Spaide R.F. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis. Am J Ophthalmol 138 (2004) 884-885
18. Spaide R.F., Sorenson J., and Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110 (2003) 1517-1525
19. Spaide R.F., Sorenson J., and Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112 (2005) 301-304
20. Spaide R.F., Sorenson J., and Maranan L. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina 25 (2005) 685-690
21. Ohji M., and Tano Y. Vitreoretinal surgery with slit-lamp illumination combined with a wide-angle-viewing contact lens. Am J Ophthalmol 137 (2004) 955-956
22. Pagot V., Mathis A., Heldenbergh O., et al. Surgery of retinal detachment of patients with pseudophakia using the panfunduscope. J Fr Ophtalmol 15 (1992) 587-591
23. Olsen T.W., Sanderson S., Feng X., and Hubbard W.C. Porcine sclera: thickness and surface area. Invest Ophthalmol Vis Sci 43 (2002) 2529-2532
24. Chin H.S., Park T.S., Moon Y.S., and Oh J.H. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina 25 (2005) 556-560
25. Beer P.M., Bakri S.J., Singh R.J., et al. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110 (2003) 681-686